Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: A randomized-controlled trial

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 9, 2006, Pages 1333-1340

  Takagi, S ^a   Utsunomiya, K ^a   Kuriyama, S ^a   Yokoyama, H ^a   Takahashi, S ^a,a   Iwabuchi, M ^b   Takahashi, H ^b   Kinouchi, Y ^a   Hiwatashi, N ^c   Funayama, Y ^a   Sasaki, I ^a   Tsuji, I ^a   Shimosegawa, T ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SENDAI CITY MEDICAL CENTER   (Japan)

^c Iwaki Kyoritsu General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIET THERAPY; ELEMENTAL DIET; ENTERIC FEEDING; FEMALE; HALF ELEMENTAL DIET; HOME CARE; HUMAN; MAINTENANCE THERAPY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; TREATMENT OUTCOME;

ADULT; CROHN DISEASE; ENTERAL NUTRITION; FEMALE; FOLLOW-UP STUDIES; FOOD, FORMULATED; HUMANS; MALE; PARENTERAL NUTRITION; RECURRENCE; TREATMENT OUTCOME;

EID: 33750032546     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03120.x     Document Type: Article

References (33)

1. Summers RW, Switz DM, Sessions JT, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847-69.
2. Malchow H, Ewe K, Brandes JW, et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249-66.
3. Jones JH, Lennard-Jones JE. Corticosteroids and corticotrophin in the treatment of Crohn's disease. Gut 1966; 7: 181-7.
4. Anthonisen P, Barany F, Folkenborg O, et al. The clinical effect of salazosulphapyridine in Crohn's disease: a controlled double-blind study. Scand J Gastroenterol 1974; 9: 549-54.
5. O'Donoghue DP, Dawson AM, Powel-Tuck K, Bown RL. Double-blind withdrawal of azathioprine as maintenance treatment for Crohn's disease. Lancet 1978; 2: 944-6.
6. Candy S, Wright JP, Gerber M, Adams G, Gerig M, Goodman R. A double-blind controlled study of azathioprine in the treatment and maintenance of remission in Crohn's disease. Gut 1995; 37: 674-8.
7. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981-7.
8. Bouhnik Y, Lemann M, Mary JY, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996; 347: 215-9.
9. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 2002; 50: 485-9.
10. Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 1999; 94: 3248-53.
11. Kumar S, Fend F, Quintanilla-Martinez L, et al. Epstein-Barr virus-positive primary gastrointestinal Hodgkin's disease: association with inflammatory bowel disease and immunosuppression. Am J Surg Pathol 2000; 24: 66-73.
12. Posthuma EFM, Westendorp RGJ, van der Sluys Veer A, Kluin-Nelemans JC, Kluin PM, Lamer CBHW. Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. Gut 1995; 36: 311-3.
13. Khatchatourian M, Seaton TL. An unusual complication of immunosuppressive therapy in inflammatory bowel disease. Am J Gastroenterol 1997; 92: 1558-60.
14. Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993; 34: 1081-5.
15. Matsueda K, Shoda R, Takazoe M, et al. Therapeutic efficacy of cyclic home elemental enteral alimentation in Crohn's disease: Japanese Cooperative Crohn's Disease Study. J Gastroenterol 1995; 30 (Suppl. 8): 91-4.
16. Hirakawa H, Fukuda Y, Tanida N, Hosomi M, Shimoyama T. Home elemental enteral hyperalimentation (HEEH) for maintenance of remission in patients with Crohn's disease. Gastroenterol Jpn 1993; 28: 379-84.
17. Verma S, Kirkwood B, Brown S, Giaffer MH. Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Dig Liver Dis 2000; 32: 769-74.
18. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial. Lancet 2002; 359: 1541-9.
19. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's Disease Activity Index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-44.
20. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979; 77: 843-6.
21. Mekhjian HS, Switz DM, Melnyk CS, Rankin GB, Brooks RK. Clinical features and natural history of Crohn's disease. Gastroenterology 1979; 77: 898-906.
22. Yao T. Criteria for diagnosis of Crohn's disease (preliminary proposal). In: Muto T, ed. Annual Report of the Research Committee of Inflammatory Bowel Disease. Tokyo: The Ministry of Health and Welfare of Japan, 1996: 63-6.
23. Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J Gastroenterol 2003; 38: 740-6.
24. Fukuda Y, Kosaka T, Okui M, Hirakawa H, Shimoyama T. Efficacy of nutritional therapy for active Crohn's disease. J Gastroenterol 1995; 30 (Suppl. ): 83-7.
25. Zoli G, Care M, Parazza M, et al. A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease. Aliment Pharmacol Ther 1997; 11: 735-40.
26. Fernández-Banares F, Cabre E, González-Huix F, Gassull MA. Enteral nutrition as primary therapy in Crohn's disease. Gut 1994; 35: S55-9.
27. Fernández-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. J Parenter Enteral Nutr 1995; 19: 356-64.
28. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2001; 3: CD000542.
29. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995; 108: 1056-67.
30. Knight C, El-Matary W, Spray C, Sandhu BK. Long-term outcome of nutritional therapy in paediatric Crohn's disease. Clin Nutr 2005; 24: 775-9.
31. O'Sullivan MA, O'Morain CA. Nutritional therapy in Crohn's disease. Inflamm Bowel Dis 1998; 4: 45-53.
32. Moran A. Bowel rest and elemental diet in Crohn's disease. Gastroenterology 1993; 104: 1238-9.
33. Lemann M, Mary JY, Colombel JF, et al. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology 2005; 128: 1812-8.